Author Details

Саржевский, Владислав Олегович

Issue Section Title File
Vol 22, No 2 (2020) Conference Proceedings Therapy of Hodgkin lymphoma in Russia during the COVID-19 pandemic PDF
(Rus)
Vol 22, No 2 (2020) Original Article High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience PDF
(Rus)
Vol 22, No 4 (2020) CLINICAL ONCOLOGY Interim results of a multicenter retrospective-prospective observational post-marketing study of Extimia® BIOCAD (INN: empegfilgrastim) to evaluate safety and efficacy in patients with lymphoproliferative diseases receiving cytotoxic therapy PDF
(Rus)
Vol 23, No 1 (2021) CLINICAL ONCOLOGY The role of positron emission tomography in different types of malignant lymphomas: the results of 2020 PDF
(Rus)
Vol 23, No 3 (2021) CLINICAL ONCOLOGY The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous? PDF
(Rus)
Vol 24, No 1 (2022) CLINICAL ONCOLOGY Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases who receive cytotoxic therapy: results of LEGERITY, the second interim analysis of multicenter retrospective-and-prospective observational post-marketing study PDF
(Rus)
Vol 25, No 4 (2023) CLINICAL ONCOLOGY Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases receiving cytotoxic therapy: results of LEGERITY, a multicenter retrospective-and-prospective observational post-marketing study PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies